Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

OTHER 7INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 3Weight Loss 2Neoplasms 2Cachexia 2Body Weight 2Anorexia 2Recurrence 1Pancreatic Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Megestrol Acetate 2ostarine 1clazakizumab 1anamorelin 1alkaloid GB18 1Sodium Chloride 1Infliximab 1Gemcitabine 1Food 1Dietary Supplements 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Cachexia × Megestrol Acetate × Clear all
NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡